Press release
Emerging Trends to Drive RNA Analysis/ Transcriptomics Market Growth at 17.1% CAGR Through 2029
RNA Analysis/ Transcriptomics Market
RNA Analysis/ Transcriptomics Market Size Growth Forecast: What to Expect by 2025?
The market size for RNA analysis/ transcriptomics has seen a substantial expansion in the past few years. The market is predicted to expand from a value of $7.72 billion in 2024 to $8.8 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.1%. The surge in the market during the historic period is as a result of cancer research and precision medicine, drug discovery and development, the diagnosis of infectious diseases, personalized medicine, funding from academic and governmental sources, as well as rising uses in agriculture.
How Will the RNA Analysis/ Transcriptomics Market Size Evolve and Grow by 2029?
The market size for RNA analysis/transcriptomics is predicted to experience substantial growth in the upcoming years, escalating to a value of $16.54 billion in 2029, boasting a compound annual growth rate (CAGR) of 17.1%. Factors contributing to this growth throughout the forecast period include single-cell RNA sequencing applications, the incorporation of RNA analysis into clinical diagnostics, RNA-based therapies and vaccines, bioinformatics, data analysis tools, and discovery and validation of biomarkers. Trends expected during the forecast period are spatial transcriptomics, in-situ RNA analysis, long-read RNA sequencing technologies, RNA editing and modification analysis, the application of AI to RNA data analysis, therapies for rare diseases based on RNA, and RNA-based liquid biopsy for the detection of cancer.
View the full report here:
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
What Drivers Are Propelling the Growth of RNA Analysis/ Transcriptomics Market Forward?
In the near future, the RNA analysis/ transcriptomics market is projected to expand due to the rising demand for personalized medicine. Personalized medicine is essentially a practice of tailoring medical care to suit the unique attributes of each patient. Personalized treatment in clinical care would greatly benefit from the proper application of RNA-Seq, given the significantly large clinical workload it can manage. For instance, the Personalized Medicine Coalition (PMC), an organization based in the US advocating for the comprehension and application of personalized medicine, stated in October 2022 that over 75,000 genetic testing products along with 300 personalized medications would be available to cater to individuals afflicted with various types of cancer, rare genetic diseases, and a host of chronic and infectious diseases. Therefore, the RNA analysis market is being propelled by this increasing demand for personalized medications.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5241&type=smp
Which Emerging Trends Are Transforming the RNA Analysis/ Transcriptomics Market in 2025?
The emergence of technological progress and creative developments in RNA analysis epitomize a growing trend in the RNA analysis/ transcriptomics market. Methods like next-generation sequencing (NGS) and RNA interference (RNAi) have bolstered precision and accuracy enabling researchers to scrutinize transcriptional activity. As an example, Illumina's Next-generation sequencing is being successfully employed to fragment DNA/RNA into numerous pieces, attach adapters, sequence the libraries, and reconstitute them to create a genomic sequence.
What Are the Key Segments in the RNA Analysis/ Transcriptomics Market?
The RNA analysis/ transcriptomics market covered in this report is segmented -
1) By Product: Reagents/Consumables, Instruments, Software
2) By Technology, Microarrays, Sequencing, Polymerase Chain Reaction RNA Interference
3) By Application: Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference
Subsegments:
1) By Reagents/Consumables: Nucleotides, Enzymes, Buffers and Solutions, Sample Preparation Kits, Sequencing Kits
2) By Instruments: Sequencers, Real-Time PCR Machines, Microarrays, Electrophoresis Systems, Robotic Liquid Handlers
3) By Software: Data Analysis Software, Bioinformatics Tools, Statistical Analysis Software, Visualization Software, Database Management Systems
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5241&type=smp
Who Are the Key Players Shaping the RNA Analysis/ Transcriptomics Market's Competitive Landscape?
Major companies operating in the RNA analysis/ transcriptomics market include Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, bioMérieux S.A., CD Genomics Inc., Eurofins Scientific SE, Merck KGaA, Pacific Biosciences of California Inc., Danaher Corporation, Genewiz Inc., Oxford Nanopore Technologies Ltd., BGI Group, Genotypic Technology Pvt. Ltd., MedGenome Labs Pvt. Ltd., Xcelris Labs Ltd., Ocimum Biosolutions Ltd., Strand Life Sciences Pvt. Ltd., SciGenom Labs Pvt. Ltd., Oncocyte Corporation, Tempus Labs Inc., ArcherDX Inc., HTG Molecular Diagnostics Inc.
What Geographic Markets Are Powering Growth in the RNA Analysis/ Transcriptomics Market?
North America was the largest region in the RNA analysis/transcriptomics market in 2024. This region is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA analysis/ transcriptomics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5241
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Trends to Drive RNA Analysis/ Transcriptomics Market Growth at 17.1% CAGR Through 2029 here
News-ID: 4080621 • Views: …
More Releases from The Business Research Company
Textile Industry Growth Fuels Expansion Of The Sewing Machine Market: A Key Cata …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Sewing Machine Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The sewing machine industry has witnessed robust growth in recent years. This promising market is projected to advance from a worth of $5.26 billion in 2024 to $5.59 billion in 2025, with an impressive compound annual growth rate (CAGR) of…
Rocket Propulsion: Critical Driver Shaping the Government And Space Company Inve …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Rocket Propulsion Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, there has been a swift expansion of the rocket propulsion market. This market is projected to increase from $7.08 billion in 2024 to $8.07 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.0%. The…
Self-Service Technologies Market Poised to Hit $67.37 Billion by 2029 with Accel …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Self-Service Technologies Market Size Growth Forecast: What to Expect by 2025?
The market size of self-service technologies has experienced robust growth over the past few years. The projected rise is from $39.45 billion in 2024 to $42.22 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.0%. Factors such as improved security…
2025-2034 SCARA Robot Market Roadmap: Insights for Competitive Advantage
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the SCARA Robot Market Size By 2025?
The market size for scara robots has seen substantial expansion in the past few years. It is anticipated to increase from $10.4 billion in 2024 to $11.97 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 15.1%. The historic growth in the…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
